PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Cardiovascular & Lipidology/NT-proBNP
Cardiovascular & LipidologyVentricular Myocardial Stretch & Hemodynamic Load

N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)

NT-proBNP is the inactive 76-amino-acid N-terminal cleavage fragment of proBNP released by ventricular myocytes in response to increased wall tension and volume overload.

Standard Range< 125 pg/mL (< 75 years)
Optimal Longevity< 50 pg/mL (Asymptomatic)
Measurement Unitpg/mL
Organ SystemVentricular Myocardial Stretch & Hemodynamic Load
Routine Panels:Heart Failure Biomarker PanelCardiovascular Hemodynamic Screen

Standard vs. Optimal Reference Rangespg/mL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: pg/mL
pg/mL
Presets:
0 pg/mLOptimal Zone Target169 pg/mL
Optimal Longevity Zone(25 pg/mL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

< 125 pg/mL (< 75 years)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

< 50 pg/mL (Asymptomatic)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Synthesized in response to myocardial stretch. Unlike active BNP, NT-proBNP has a longer circulating half-life (120 minutes) and is cleared predominantly by renal excretion, serving as an exquisitely sensitive marker of subclinical left ventricular strain.

Differential Diagnosis

Elevated Levels (NT-proBNP High)

  • •Heart failure (reduced or preserved ejection fraction)
  • •Atrial fibrillation and tachyarrhythmias
  • •Chronic kidney disease (impaired clearance)
  • •Pulmonary arterial hypertension

Low Levels (NT-proBNP Low)

  • •Youthful left ventricular compliance and normal intracardiac pressures

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the cellular and molecular level, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) is central to lipoprotein particle assembly, apolipoprotein-receptor interactions, and subendothelial retention kinetics. Synthesis occurs primarily within hepatocytes and enterocytes, regulated by transcriptional co-activators (such as SREBP-2 and PPAR-alpha) and microsomal triglyceride transfer protein (MTP). Particle clearance is mediated through high-affinity endocytic receptors (including LDLR, LRP1, and scavenger receptors SR-B1). Circulating plasma half-life ranges from 2 to 4 days. Transcytosis across vascular endothelial cell monolayers occurs via scavenger receptor class B type 1 (SR-B1) and activin-like kinase 1 (ALK1), trapping particles within the subendothelial proteoglycan matrix where oxidative modification initiates foam cell formation.
Longevity Risk Architecture & Epidemiology
Low baseline NT-proBNP (<50 pg/mL) indicates youthful myocardial compliance and the absence of subclinical heart failure with preserved ejection fraction (HFpEF).
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Standard testing requires a 10 to 12 hour overnight fast to minimize postprandial chylomicron interference, although NT-proBNP direct immunoassay is less sensitive to prandial state than calculated LDL-C. Avoid strenuous high-intensity exercise 24 hours prior to blood draw. Serum separator tubes (SST) or EDTA plasma should be centrifuged within 2 hours. High-dose biotin (>5 mg/day) supplementation may interfere with competitive streptavidin-biotin immunoassays, requiring a 48-hour washout period.

Reflexive Testing Protocol:

  • Advanced Lipoprotein Particle Quantification (NMR spectroscopy or ion mobility LDL-P)
  • Lipoprotein(a) [Lp(a)] baseline evaluation for genetic cardiovascular risk stratification
  • Coronary Artery Calcium (CAC) score via non-contrast cardiac CT to evaluate calcified plaque burden
  • High-sensitivity C-Reactive Protein (hs-CRP) to assess systemic vascular inflammatory tone
  • Carotid intima-media thickness (CIMT) duplex ultrasound to assess subclinical atherosclerosis
Clinical Citations & Primary Literature (1)
  • [1]Natriuretic Peptides in Heart Failure and Cardiovascular Prevention - New England Journal of Medicine (2021). PMID: 33792075
Common Panels:Heart Failure Biomarker PanelCardiovascular Hemodynamic Screen
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Cardiovascular & Lipidology Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
High-Sensitivity Cardiac Troponin T
hs-cTnT · < 6 ng/L (Basal Longevity Target)
PreviousRemnant Cholesterol (Remnant-C)Cardiovascular & LipidologyNextHigh-Sensitivity Cardiac Troponin T (hs-cTnT)Cardiovascular & Lipidology